查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1840765

生物製药辅料市场（按产品、供应商、配方类型和最终用户划分）—2025-2032 年全球预测

Biopharmaceutical Excipients Market by Product, Source, Formulation Type, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年生物製药辅料市场将成长至 77.2 亿美元，复合年增长率为 9.94%。

主要市场统计数据
基准年2024年 36.1亿美元
预计2025年 39.6亿美元
预测年份：2032年 77.2亿美元
复合年增长率（%） 9.94%

生物製药辅料已远远超越了其在药物製剂中作为惰性载体的传统作用。如今，这些功能性成分被认为对药物稳定性、生物有效性、可生产性和病患安全具有关键影响。随着市场朝向复杂生技药品、个人化疗法和组合药物方向发展，对辅料的需求呈指数级增长。决策者现在需要深入了解粘合剂、被覆剂、稀释剂、崩坏、润滑剂和其他类别的辅料在生产、储存和运输过程中如何与活性药物成分相互作用。

本执行摘要概述了定义现代辅料市场的基本要素，为市场奠定了基础。它提供了塑造行业发展的主要讯息，探讨了影响全球供应供应商的监管和地缘政治趋势，并根据产品、供应商、配方类型和最终用户定义了关键细分市场。这个背景框架提供了对区域动态、竞争定位的洞察，并为寻求应对不确定性并利用新机会的行业领导者提供了切实可行的建议。

探索透过技术进步和监管创新塑造生物製药辅料格局的快速变化

在製剂科学、数位技术和永续性要求的推动下，生物製药辅料产业正在经历转型。在生技药品和基因疗法兴起的推动下，製剂设计师正在引入新型聚合物粘合剂和标靶释放被覆剂，以满足敏感分子独特的稳定性要求。同时，人工智慧和机器学习正在实现更具预测性的辅料筛检，从而缩短开发时间并降低实验失败率。

此外，世界各地的监管机构正在加强辅料特性和安全方面的指导，鼓励製造商采用更严格的「品质源于设计」原则。同时，该行业正在拥抱绿色化学，筹资策略专注于可再生、天然辅料和环保製造流程。因此，竞争格局正转向那些能够证明其可追溯性强、水分含量低且环境足迹较小的供应商，为创新和合规树立了新的标竿。

2025年美国新关税对生物製药辅料供应链和成本结构影响的全面评估

美国2025年对各种进口辅料原料征收关税，为本已复杂的供应链带来了新的复杂性。由于关税影响关键的聚合物、多元醇和界面活性剂，製造商正努力应对不断上涨的采购成本，而这些成本会波及配方预算和商业化计画。这直接导致替代原料的搜寻速度显着加快，人们对国内製造能力的兴趣也重新燃起。

此外，关税带来的成本压力凸显了供应商关係敏捷性的重要性，迫使企业加强与受关税影响较小的地区上游生产商的伙伴关係。同时，配方团队正在重新审视辅料的规格，并寻找在不影响性能的情况下与低成本替代品进行对标的机会。总而言之，这些行动正在重塑辅料供应链管理流程，并要求整个价值链上的相关人员保持敏捷。

详细分析产品来源配方和最终用户细分，为生物製药辅料市场策略提供可行的见解

对市场区隔的详细研究可以揭示可为策略决策提供资讯的关键见解。按产品类型划分，市场包括粘合剂，例如纤维素衍生物、羟丙基甲基纤维素、聚维酮和改质淀粉；被覆剂，从控制释放和肠溶包衣到薄膜和糖基；稀释剂，例如磷酸钙、乳糖和微晶纤维素；崩坏；润滑剂；多元醇，例如甘露醇和山梨糖醇；防化剂和悬浮液以及悬浮液和表面活性剂；赋形剂来源可以是天然的，也可以是透过合成过程获得的，每种工艺都有不同的纯度水平、永续性概况和监管考虑。以剂型划分，市场包括注射剂（肌肉注射、静脉注射和皮下注射）；口服剂型（胶囊、粉末和片剂）；以及外用剂型（乳膏、凝胶、软膏和洗剂），每种剂型都需要特定的功能特性。最后，最终用户的频谱包括生物製药和製药製造商、合约开发和製造组织以及研究机构，这凸显了相关人员必须应对的需求和筹资策略的多样性。

美洲、欧洲、中东和非洲以及亚太地区生物製药辅料市场的区域表现动态和成长轨迹

区域分析显示，每个地区的成长动力因创新生态系统、法规环境和供应链能力而异。在美洲，对先进药物输送平台的强劲需求推动了对新型黏合剂和涂层技术的投资，而回流奖励和关税压力（尤其是在美国）则推动了高纯度辅料的国内生产。向东看，在严格的环境法规和促​​进跨境研发计划的合作联盟的推动下，欧洲、中东和非洲正在稳步吸收绿色和功能性辅料。同时，亚太地区仍然是产能扩张的温床，中国、印度和东南亚的主要生产商利用成本竞争力和综合供应链为区域和全球市场提供服务。各地区的一个一致主题是强调供应安全、可追溯性和监管完整性，因为製造商试图减轻地缘政治风险并保持对关键原材料的持续取得。

竞争情报揭示了主要产业参与者的策略性倡议以及推动生物製药辅料产业成长的创新途径

产业主要参与者正加紧努力，透过高性能辅料创新和策略伙伴关係来确保竞争优势。一些领先的供应商已经建立了聚合物科学和奈米技术专业中心，从而能够开发功能性包衣，以增强靶向释放特性并提高患者依从性。同时，辅料製造商与学术研究机构之间的合作关係正在加速新型製剂平台的竞争前研究。

此外，企业正在利用数位平台提供整合生命週期管理服务，包括即时品质监控、生产线预测性维护以及与客户进行材料资料的数位交换。鑑于近期关税引发的供应链中断，相关人员致力于确保原材料的稳定供应，因此与特种化学品製造商和原材料供应商的合作也不断增加。这些策略倡议彰显了该产业致力于透过技术、卓越服务和弹性筹资策略实现差异化的决心。

为产业领导者提供实际的策略建议，以加速创新、优化供应链并增强辅料开发的市场推广

为了在这种动态环境中取得成功，产业领导者应采取多管齐下的策略。首先，整合地缘政治稳定的地区的二级供应商可以实现采购多元化，降低关税风险并防止供应中断。同时，投资模组化和灵活的製造能力，可以透过现有工厂和合约伙伴关係关係快速扩大和重新配置生产线。

此外，将研发预算转向永续的辅料平台，使其在提供同等性能的同时减少生态足迹，既能满足监管期望，又能满足最终用户的需求。与监管机构合作，为新型材料製定明确的品质标准，可以简化核准流程。最后，利用数位工具进行预测分析和材料资讯学，可以提高配方成功率，缩短上市时间，并最终增强竞争优势。

详述数据收集三角测量和同行检验过程的稳健调查方法，支持对生物製药辅料分析的洞察

本分析基于一套稳健的方法论，结合了全面的资料收集和专家检验。二次研究涵盖了对监管指南、专利、白皮书和技术出版物的广泛查阅，以了解关键辅料的功能属性和合规性要求。随后，我们也对领先生物製药公司的配方科学家、采购负责人和监管专家进行了初步访谈，以获得新兴挑战和最佳实践的第一手见解。

为确保准确性和客观性，资料点透过多个资讯来源进行三角测量，包括专有供应商资料库和学术研究资料库。定量输入由材料性能测试报告支持，定性趋势则透过迭代审查週期与行业专家进行交叉检验。这种结构化方法确保本文所呈现的调查结果能反映决策者可获得的最新、最可靠且可操作的资讯。

综合结论强调了生物製药辅料产业的主要趋势、挑战和机会，为决策提供参考

摘要：生物製药辅料市场正处于科技创新、监管变革和地缘政治变化的十​​字路口。新一代粘合剂、被覆剂和输送系统的变革潜力与应对新实施的关税和供应链限制的紧迫性相得益彰。細項分析揭示了产品类型、供应商、配方类型和最终用户的细微需求，而区域观点则突显了影响成长轨迹和投资重点的多样化动态。

竞争格局正被那些在功能创新、永续实践和供应链韧性方面表现卓越的企业重新定义。展望未来，那些拥抱多元化、数位化和协作监管的组织将更有能力抓住新的机会。最终，在这一领域的成功取决于将尖端科学与战略远见和敏捷运营相结合。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 整合数位双胞胎技术实现预测性添加剂性能优化
  • 生物製药製造中朝向永续和可生物降解的辅料迈进
  • 下一代生物製药製造中越来越多地采用高纯度、无动物性辅料
  • mRNA 疫苗开发对客製化辅料配方的需求不断增长
  • 监管协调工作已使全球添加剂的认证标准标准化
  • 扩大辅料供应商与生技公司在新型输送系统的合作
  • 扩大 cGMP 製造能力以满足日益增长的生物添加剂需求
  • 供应链多角化策略，增强疫情后辅料采购的弹性

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第 8 章：生物製药辅料市场（按产品）

  • 黏合剂
    • 纤维素黏合剂
    • 羟丙基甲基纤维素（HPMC）
    • 聚维酮（聚乙烯吡咯烷酮或PVP）
    • 淀粉和改性淀粉
  • 涂层
    • 控释包衣
    • 肠溶衣
    • 薄膜包衣
    • 密封涂层
    • 糖霜
  • 冲淡
    • 磷酸钙
    • 乳糖
    • 微晶纤维素
  • 崩坏
  • 润滑剂和助流剂
  • 多元醇
    • 甘露醇
    • 山梨糖醇
  • 防腐剂
  • 增溶剂和界面活性剂/乳化剂
    • 酯
    • 聚山梨醇酯
    • 三酸甘油酯
  • 悬浮剂和增稠剂

9. 生物製药辅料市场（依来源）

  • 天然辅料
  • 合成辅料

第 10 章：生物製药辅料市场（依配方类型）

  • 注射
    • 肌肉注射
    • 静脉
    • 皮下
  • 口服製剂
    • 胶囊
    • 粉末
    • 药片
  • 局部製剂
    • 奶油
    • 凝胶和软膏
    • 洗剂

第 11 章：生物製药辅料市场（以最终用户划分）

  • 生物製药和製药公司
  • 契约製造
  • 研究机构

第 12 章：生物製药辅料市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 13 章：生物製药辅料市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 14 章：各国生物製药辅料市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • BASF SE
    • The Dow Chemical Company
    • ABITEC Corporation
    • Asahi Kasei Corporation
    • Actylis
    • Ashland Inc.
    • Avantor, Inc.
    • Clariant International Ltd.
    • Colorcon Ltd.
    • Croda International PLC
    • DFE Pharma GmbH & Co KG
    • Eastman Chemical Company
    • Evonik Industries AG
    • Fuji Chemical Industries Co., Ltd.
    • IMCD NV
    • Innophos Holdings, Inc.
    • International Flavors & Fragrances Inc.
    • JRS PHARMA GmbH+Co. KG
    • Kerry Group PLC
    • Meggle Group GmbH
    • Merck KGaA
    • Mitsubishi Chemical Group Corporation
    • NOF Corporation
    • Novo Nordisk A/S
    • Pfanstiehl, Inc.
    • Roquette Freres SA
    • Shin-Etsu Chemical Co., Ltd.
    • Sigachi Industries Limited
    • Spectrum Laboratory Products, Inc.
    • SPI Pharma, Inc. By Associated British Foods
    • The Archer-Daniels-Midland Company
    • The Lubrizol Corporation
    • Wacker Chemie AG
Product Code: MRR-A339DAEFAD78

The Biopharmaceutical Excipients Market is projected to grow by USD 7.72 billion at a CAGR of 9.94% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.61 billion
Estimated Year [2025] USD 3.96 billion
Forecast Year [2032] USD 7.72 billion
CAGR (%) 9.94%

Biopharmaceutical excipients have evolved far beyond their traditional role as inert carriers in drug formulation. Today, these functional ingredients are recognized for their critical influence on drug stability, bioavailability, manufacturability, and patient safety. As the landscape shifts toward complex biologics, personalized therapies, and combination products, the demands placed on excipients have grown exponentially. Decision makers now require a nuanced understanding of how binders, coatings, diluents, disintegrants, lubricants, and other categories interact with active pharmaceutical ingredients during production, storage, and delivery.

In this executive summary, we set the stage by outlining the foundational elements that define the modern excipients market. We introduce the primary drivers reshaping the industry, survey the regulatory and geopolitical currents that affect global supply chains, and delineate key segmentation dimensions by product, source, formulation type, and end user. With this contextual framework in place, we deliver insights into regional dynamics, competitive positioning, and actionable recommendations for industry leaders seeking to navigate uncertainty and capitalize on emerging prospects.

Exploring Rapid Transformations Reshaping the Biopharmaceutical Excipients Landscape Through Technological Advances and Regulatory Innovation

The biopharmaceutical excipients landscape is currently undergoing a wave of transformation fueled by advances in formulation science, digital technologies, and sustainability imperatives. Driven by the rise of biologics and gene therapies, formulators are increasingly incorporating novel polymeric binders and targeted release coatings to address the unique stability requirements of sensitive molecules. At the same time, artificial intelligence and machine learning are enabling more predictive excipient screening, accelerating development timelines and reducing experimental failure rates.

Furthermore, regulatory agencies around the world have tightened guidelines related to excipient characterization and safety, prompting manufacturers to adopt more rigorous quality by design principles. Concurrently, the industry is embracing green chemistry practices, with sourcing strategies focused on renewable natural excipients and ecofriendly manufacturing processes. As a result, the competitive environment is shifting toward suppliers that can demonstrate robust traceability, low aqueous content, and reduced environmental footprints, thereby creating a new benchmark for innovation and compliance.

Evaluating the Comprehensive Impact of Newly Implemented United States Tariffs in 2025 on Biopharmaceutical Excipients Supply Chain and Cost Structures

The implementation of United States tariffs in 2025 on a range of imported excipient raw materials has introduced fresh complexities into an already intricate supply chain. With levies impacting key polymers, polyols, and surfactants, manufacturers are grappling with higher procurement costs that ripple through formulation budgets and commercialization plans. As a direct consequence, there has been a marked acceleration in the search for alternative ingredient sources and a renewed interest in domestic production capabilities.

Moreover, the tariff-induced cost pressures have underscored the need for agility in supplier relationships, prompting companies to strengthen partnerships with upstream producers in regions less affected by these duties. In parallel, formulation teams are reexamining excipient specifications to identify opportunities for benchmarking lower-cost analogs without compromising performance. Collectively, these actions are reshaping the operational playbook for excipient supply chain management and demanding agile responses from stakeholders across the value chain.

In-Depth Analysis of Product Source Formulation and End User Segmentation Delivering Actionable Insights for Biopharmaceutical Excipients Market Strategy

A granular examination of market segmentation reveals pivotal insights that inform strategic decision making. When categorizing by product, the landscape spans binders such as cellulosic derivatives, hydroxypropyl methylcellulose, povidone, and modified starches; coatings ranging from controlled release and enteric to film and sugar-based variants; diluents including calcium phosphates, lactose, and microcrystalline cellulose; as well as disintegrants, lubricants, polyols like mannitol and sorbitol, preservatives, solubilizers and surfactants forming emulsifier systems, and suspending agents. Considering source, excipients derive from either natural origins or synthetic processes, each offering distinct purity, sustainability profiles, and regulatory considerations. In terms of formulation type, the market covers injectables with intramuscular, intravenous, and subcutaneous routes; oral delivery systems encompassing capsules, powders, and tablets; and topical forms such as creams, gels, ointments, and lotions, each demanding specific functional attributes. Finally, the end user spectrum, comprising biopharmaceutical and pharmaceutical manufacturers, contract development and manufacturing organizations, and research institutions, underscores the diversity of requirements and procurement strategies that stakeholders must navigate.

Regional Performance Dynamics and Growth Trajectories Across the Americas Europe Middle East Africa and Asia Pacific Biopharmaceutical Excipients Markets

Regional analysis underscores differentiated growth dynamics driven by local innovation ecosystems, regulatory environments, and supply chain capabilities. In the Americas, strong demand for advanced drug delivery platforms is catalyzing investment in novel binder and coating technologies, particularly in the United States where reshoring incentives and tariff pressures converge to support domestic manufacturing of high-purity excipients. Moving eastward, Europe, Middle East and Africa exhibit steady uptake of green and functional excipients, spurred by stringent environmental regulations and collaborative consortiums that foster cross-border R&D initiatives. Meanwhile, Asia-Pacific remains a hotbed of capacity expansion, with major producers in China, India, and Southeast Asia leveraging cost competitiveness and integrated supply chains to serve both regional and global markets. Consistent across all regions is an emphasis on supply security, traceability, and regulatory alignment, as manufacturers seek to mitigate geopolitical risks and maintain uninterrupted access to critical materials.

Competitive Intelligence Revealing Key Industry Players Strategic Initiatives and Innovation Pathways Driving Growth in Biopharmaceutical Excipients Sector

Key industry participants are intensifying efforts to secure competitive advantage through innovation in high-performance excipients and strategic partnerships. Several leading suppliers have established dedicated centers of excellence for polymer science and nanotechnology, enabling the development of functional coatings that enhance targeted release profiles and improve patient compliance. Simultaneously, collaborative alliances between excipient producers and academic research institutions are accelerating pre-competitive studies on novel formulation platforms.

In addition, companies are leveraging digital platforms to offer lifecycle management services that integrate real-time quality monitoring, predictive maintenance of production lines, and digital exchange of material data with customers. Partnerships with specialty chemical manufacturers and raw material providers are also on the rise, as stakeholders aim to ensure uninterrupted feedstock availability in light of recent tariff-driven supply chain disruptions. Taken together, these strategic initiatives underscore the industry's commitment to differentiation through technology, service excellence, and resilient sourcing strategies.

Actionable Strategic Recommendations Enabling Industry Leaders to Accelerate Innovation Optimize Supply Chains and Enhance Market Position in Excipients Development

To thrive in this dynamic environment, industry leaders should adopt a multi-pronged approach. First, diversifying sourcing by integrating second-tier suppliers from geopolitically stable regions can mitigate tariff risk and prevent disruptions. At the same time, investing in modular, flexible manufacturing capabilities-both in existing plants and through contract partnerships-will allow rapid scale-up or reconfiguration of production lines.

Furthermore, directing R&D budgets toward sustainable excipient platforms that deliver comparable performance with a reduced ecological footprint will address both regulatory expectations and end-user demand. Collaborative engagement with regulatory bodies to establish clear quality standards for novel materials can streamline approval timelines. Finally, harnessing digital tools for predictive analytics and material informatics will improve formulation success rates and accelerate time to market, ultimately enhancing competitiveness.

Robust Research Methodology Detailing Data Collection Triangulation and Expert Validation Processes Underpinning Insights in Biopharmaceutical Excipients Analysis

This analysis is built upon a robust methodology combining comprehensive data aggregation and expert validation. Initially, secondary research involved a thorough review of regulatory guidelines, patents, white papers, and technical publications to map the functional attributes and compliance requirements of key excipients. Following this, primary interviews were conducted with formulation scientists, procurement executives, and regulatory specialists from leading biopharmaceutical organizations to capture firsthand insights into emerging challenges and best practices.

To ensure accuracy and objectivity, data points were triangulated across multiple sources, including proprietary supplier databases and academic research repositories. Quantitative inputs were corroborated through material property testing reports, while qualitative trends were cross-verified with industry experts during iterative review cycles. This structured approach guarantees that the findings presented herein reflect the most current, reliable, and actionable intelligence available to decision makers.

Consolidated Conclusions Emphasizing Critical Trends Challenges and Opportunities to Inform Decision Making in the Biopharmaceutical Excipients Landscape

In summary, the biopharmaceutical excipients market stands at the intersection of scientific innovation, regulatory evolution, and geopolitical shifts. The transformative potential of next-generation binders, coatings, and delivery systems is now matched by the urgency to navigate newly imposed tariffs and supply chain constraints. Segmentation analysis reveals the nuanced requirements across product categories, sources, formulation types, and end users, while regional perspectives highlight the divergent dynamics that influence growth trajectories and investment priorities.

Competitive landscapes are being redefined by players that excel in functional innovation, sustainable practices, and supply chain resilience. Moving forward, organizations that embrace diversification, digitalization, and collaborative regulation will be best positioned to harness emerging opportunities. Ultimately, success in this sector will depend on the ability to integrate cutting-edge science with strategic foresight and operational agility.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of digital twin technologies for predictive excipient performance optimization
  • 5.2. Shift toward sustainable and biodegradable excipients in biopharmaceutical production
  • 5.3. Increasing adoption of high-purity, animal-free excipients for next-gen biologics manufacturing
  • 5.4. Rising demand for tailored excipient formulations in mRNA-based vaccine development
  • 5.5. Regulatory harmonization efforts driving standardized excipient qualification globally
  • 5.6. Growing collaborations between excipient suppliers and biotech firms for novel delivery systems
  • 5.7. Scaling up cGMP manufacturing capabilities to meet surging biologic excipient requirements
  • 5.8. Supply chain diversification strategies enhancing resilience in excipient sourcing post pandemic

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biopharmaceutical Excipients Market, by Product

  • 8.1. Binders
    • 8.1.1. Cellulosic Binders
    • 8.1.2. Hydroxypropyl Methylcellulose (HPMC)
    • 8.1.3. Povidone (Polyvinylpyrrolidone or PVP)
    • 8.1.4. Starch & Modified Starches
  • 8.2. Coatings
    • 8.2.1. Controlled Release Coatings
    • 8.2.2. Enteric Coatings
    • 8.2.3. Film Coatings
    • 8.2.4. Seal Coatings
    • 8.2.5. Sugar Coatings
  • 8.3. Diluents
    • 8.3.1. Calcium Phosphates
    • 8.3.2. Lactose
    • 8.3.3. Microcrystalline Cellulose
  • 8.4. Disintegrants
  • 8.5. Lubricants & Glidants
  • 8.6. Polyols
    • 8.6.1. Mannitol
    • 8.6.2. Sorbitol
  • 8.7. Preservatives
  • 8.8. Solubilizers & Surfactants/Emulsifiers
    • 8.8.1. Esters
    • 8.8.2. Polysorbates
    • 8.8.3. Triglycerides
  • 8.9. Suspending & Viscosity Agents

9. Biopharmaceutical Excipients Market, by Source

  • 9.1. Natural Excipients
  • 9.2. Synthetic Excipients

10. Biopharmaceutical Excipients Market, by Formulation Type

  • 10.1. Injectable Formulations
    • 10.1.1. Intramuscular
    • 10.1.2. Intravenous
    • 10.1.3. Subcutaneous
  • 10.2. Oral Formulations
    • 10.2.1. Capsules
    • 10.2.2. Powders
    • 10.2.3. Tablets
  • 10.3. Topical Formulations
    • 10.3.1. Creams
    • 10.3.2. Gels & Ointments
    • 10.3.3. Lotions

11. Biopharmaceutical Excipients Market, by End User

  • 11.1. Biopharmaceutical & Pharmaceutical Companies
  • 11.2. Contract Manufacturers
  • 11.3. Research Institutes

12. Biopharmaceutical Excipients Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Biopharmaceutical Excipients Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Biopharmaceutical Excipients Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. BASF SE
    • 15.3.2. The Dow Chemical Company
    • 15.3.3. ABITEC Corporation
    • 15.3.4. Asahi Kasei Corporation
    • 15.3.5. Actylis
    • 15.3.6. Ashland Inc.
    • 15.3.7. Avantor, Inc.
    • 15.3.8. Clariant International Ltd.
    • 15.3.9. Colorcon Ltd.
    • 15.3.10. Croda International PLC
    • 15.3.11. DFE Pharma GmbH & Co KG
    • 15.3.12. Eastman Chemical Company
    • 15.3.13. Evonik Industries AG
    • 15.3.14. Fuji Chemical Industries Co., Ltd.
    • 15.3.15. IMCD N.V.
    • 15.3.16. Innophos Holdings, Inc.
    • 15.3.17. International Flavors & Fragrances Inc.
    • 15.3.18. JRS PHARMA GmbH + Co. KG
    • 15.3.19. Kerry Group PLC
    • 15.3.20. Meggle Group GmbH
    • 15.3.21. Merck KGaA
    • 15.3.22. Mitsubishi Chemical Group Corporation
    • 15.3.23. NOF Corporation
    • 15.3.24. Novo Nordisk A/S
    • 15.3.25. Pfanstiehl, Inc.
    • 15.3.26. Roquette Freres S.A.
    • 15.3.27. Shin-Etsu Chemical Co., Ltd.
    • 15.3.28. Sigachi Industries Limited
    • 15.3.29. Spectrum Laboratory Products, Inc.
    • 15.3.30. SPI Pharma, Inc. By Associated British Foods
    • 15.3.31. The Archer-Daniels-Midland Company
    • 15.3.32. The Lubrizol Corporation
    • 15.3.33. Wacker Chemie AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BIOPHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. BIOPHARMACEUTICAL EXCIPIENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSIC BINDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSIC BINDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSIC BINDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSIC BINDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSIC BINDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSIC BINDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POVIDONE (POLYVINYLPYRROLIDONE OR PVP), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POVIDONE (POLYVINYLPYRROLIDONE OR PVP), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POVIDONE (POLYVINYLPYRROLIDONE OR PVP), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POVIDONE (POLYVINYLPYRROLIDONE OR PVP), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POVIDONE (POLYVINYLPYRROLIDONE OR PVP), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POVIDONE (POLYVINYLPYRROLIDONE OR PVP), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH & MODIFIED STARCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH & MODIFIED STARCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH & MODIFIED STARCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH & MODIFIED STARCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH & MODIFIED STARCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH & MODIFIED STARCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTROLLED RELEASE COATINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTROLLED RELEASE COATINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTROLLED RELEASE COATINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTROLLED RELEASE COATINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTROLLED RELEASE COATINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTROLLED RELEASE COATINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ENTERIC COATINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ENTERIC COATINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ENTERIC COATINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ENTERIC COATINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ENTERIC COATINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ENTERIC COATINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FILM COATINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FILM COATINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FILM COATINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FILM COATINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FILM COATINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FILM COATINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEAL COATINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEAL COATINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEAL COATINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEAL COATINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEAL COATINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEAL COATINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGAR COATINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGAR COATINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGAR COATINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGAR COATINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGAR COATINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGAR COATINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DILUENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYSORBATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYSORBATES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYSORBATES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYSORBATES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYSORBATES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYSORBATES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL EXCIPIENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL EXCIPIENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL EXCIPIENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL EXCIPIENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL EXCIPIENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL EXCIPIENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC EXCIPIENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC EXCIPIENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC EXCIPIENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC EXCIPIENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC EXCIPIENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC EXCIPIENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE FORMULATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL FORMULATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL FORMULATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CREAMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CREAMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CREAMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CREAMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CREAMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELS & OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELS & OINTMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELS & OINTMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELS & OINTMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELS & OINTMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELS & OINTMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LOTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LOTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LOTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LOTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LOTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LOTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BIOPHARMACEUTICAL & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL BIOPHARMACEUTIC